An Unusual Presentation of Juvenile Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is an autoimmune disease involving multiple organ systems that often mimic other conditions. The majority of patients with SLE show mucocutaneous manifestations, fatigue, fever, rheumatological manifestations, and weight loss as initial symptoms. SLE is classically managed medically with hydroxychloroquine, glucocorticoids, and/or immunosuppressives. Juvenile-onset systemic lupus erythematosus (jSLE) patients, who account for about 20% of SLE patients, tend to have earlier development of end-organ damage, and increased need for immunosuppressive therapies. We present a 12-year-old woman with a history of atopic conditions who initially presented for treatment of mild gastritis and a duodenal ulcer diagnosed by esophagogastroduodenoscopy (EGD). Several months later, the patient developed hematological abnormalities and rashes classically associated with SLE. Healthcare providers need to be aware of the distinct features of jSLE and modalities of treatment.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2024-10-12
DOI
https://doi.org/10.7759/cureus.71301
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Unusual Presentation of Juvenile Systemic Lupus Erythematosus

Sarah Louis, Jodi Fiedler, Yash Nagpal, Charles H. Hennekens
Cureus
Systemic Lupus Erythematosus Research
article

An Unusual Presentation of Juvenile Systemic Lupus Erythematosus

Sarah Louis, Jodi Fiedler, Yash Nagpal, Charles H. Hennekens
article en

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease involving multiple organ systems that often mimic other conditions. The majority of patients with SLE show mucocutaneous manifestations, fatigue, fever, rheumatological manifestations, and weight loss as initial symptoms. SLE is classically managed medically with hydroxychloroquine, glucocorticoids, and/or immunosuppressives. Juvenile-onset systemic lupus erythematosus (jSLE) patients, who account for about 20% of SLE patients, tend to have earlier development of end-organ damage, and increased need for immunosuppressive therapies. We present a 12-year-old woman with a history of atopic conditions who initially presented for treatment of mild gastritis and a duodenal ulcer diagnosed by esophagogastroduodenoscopy (EGD). Several months later, the patient developed hematological abnormalities and rashes classically associated with SLE. Healthcare providers need to be aware of the distinct features of jSLE and modalities of treatment.

CureusVol. 16(10)
Johns Hopkins University (US), Florida Atlantic University (US)
Openalex Percentile: Top 69%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

An Unusual Presentation of Juvenile Systemic Lupus Erythematosus — Sarah Louis, Jodi Fiedler, et al. · Cureus (2024) | TGRS Research Map | TGRS